Buchumschlag

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Katharina Bolsewig, Hester Blok, Eline A. J. Willemse, Rob B. M. Groot Zwaaftink, Minke Kooistra, Ellen M. A. Smets, Charlotte E. Teunissen, Leonie N. C. Visser
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
von: Thomas Claessen, et al.
Veröffentlicht: (2026)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
von: Thomas Claessen, et al.
Veröffentlicht: (2025)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
von: Robert Perneczky, et al.
Veröffentlicht: (2025)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
von: Steffi De Meyer, et al.
Veröffentlicht: (2025)

Ethics of disclosure of onset‐predictive biomarker test results for genetic frontotemporal dementia in the research context
von: Charlotte H. Graafland, et al.
Veröffentlicht: (2025)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
von: Marijke E. Stokkel, et al.
Veröffentlicht: (2026)

Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
von: Patrick H. Luckett, et al.
Veröffentlicht: (2026)

Clinical performance of scalable automated p‐tau 217 multi‐analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay
von: David H. Wilson, et al.
Veröffentlicht: (2025)

Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
von: Christopher Gonzalez Corona, et al.
Veröffentlicht: (2026)

ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes
von: Luciana Mascarenhas Fonseca, et al.
Veröffentlicht: (2024)

Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant
von: Anneka E. Blankenship, et al.
Veröffentlicht: (2024)

Blood biomarkers for Alzheimer's disease: Reliable change and impacts of renal and blood–brain barrier function
von: Anders Behrens, et al.
Veröffentlicht: (2025)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
von: Iolanda Lázaro, et al.
Veröffentlicht: (2024)

Sex‐specific blood biomarkers linked to memory changes in middle‐aged adults: The Framingham Heart Study
von: Huitong Ding, et al.
Veröffentlicht: (2024)

Awareness, attitudes, and beliefs of dementia in Indonesia
von: Nicolas Farina, et al.
Veröffentlicht: (2024)

Feasibility and pilot testing of a non‐randomized teacher training program to improve knowledge and attitudes toward aging and dementia in public schools in Brazil: The ARISE program
von: Karen Leticia Pulgatti, et al.
Veröffentlicht: (2025)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
von: Rosanne L. van den Berg, et al.
Veröffentlicht: (2025)

Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting
von: Rebecca Z. Rousset, et al.
Veröffentlicht: (2024)

Subjective memory concerns and AD/ADRD plasma biomarker associations in HABS‐HD
von: Kelsey R. Thomas, et al.
Veröffentlicht: (2026)

Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care
von: Soo Borson, et al.
Veröffentlicht: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
von: Rachel R. Jin, et al.
Veröffentlicht: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
von: Darren M. Lipnicki, et al.
Veröffentlicht: (2026)

Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
von: Oana C. Marian, et al.
Veröffentlicht: (2025)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
von: Emily K. Schworer, et al.
Veröffentlicht: (2024)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
von: Alexandra Paget‐Blanc, et al.
Veröffentlicht: (2025)

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
von: Angela van der Putten‐Toorenburg, et al.
Veröffentlicht: (2026)

Association between BrainAGE and Alzheimer's disease biomarkers
von: Yousaf Abughofah, et al.
Veröffentlicht: (2025)

Proteomic profiling identifies serpin G1, ApoA‐II, and LBP as potential biomarkers of dementia in an Egyptian cohort
von: Shimaa A. Heikal, et al.
Veröffentlicht: (2025)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
von: Sofia Toniolo, et al.
Veröffentlicht: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
von: Russell Banks, et al.
Veröffentlicht: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
von: Andrée‐Ann Baril, et al.
Veröffentlicht: (2024)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
von: Faheem Arshad, et al.
Veröffentlicht: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
von: Julius Opwonya, et al.
Veröffentlicht: (2024)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
von: John T. O'Brien
Veröffentlicht: (2025)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
von: Soheil Mohammadi, et al.
Veröffentlicht: (2025)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
von: Lars Frings, et al.
Veröffentlicht: (2025)

Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's disease
von: Alireza Shaabanpoor Haghighi, et al.
Veröffentlicht: (2025)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
von: Frederikke Kragh Clemmensen, et al.
Veröffentlicht: (2026)

Machine learning models of Alzheimer's disease spectrum using blood tests
von: Nicola Walter Falasca, et al.
Veröffentlicht: (2025)

Assessment of circulating apoE4 levels from dried blood spot samples in a large survey setting
von: Nis Borbye‐Lorenzen, et al.
Veröffentlicht: (2024)